Introducing the Pneumococcal Conjugate Vaccine (PCV) in Somalia, Guinea, South Sudan, and Chad

LOOK AT THIS IF YOU'RE INTERESTED IN:

Learning about actions to accelerate introduction of the Pneumococcal Conjugate Vaccine (PCV) in Somalia, Guinea, South Sudan, and Chad.

HOW YOU CAN USE THIS MATERIAL:

Stakeholders in countries that have yet to introduce PCV can adapt the actions and lessons from this report to accelerate the achievement of their nation’s child health goals.

OVERVIEW:

There are still countries that have yet to introduce PCV. Among them are Somalia, Guinea, South Sudan, and Chad, where more than 40,000 children died from pneumonia, and an additional 10,000 from meningitis and sepsis, in 2019, according to the Global Burden of Disease (GBD). It is critical that the remaining African countries can both introduce the PCV by 2025 and sustain the high rates of coverage needed to deliver health benefits for children and adults. This report offers 10 actions to accelerate introduction of the PCV in Somalia, Guinea, South Sudan and Chad in 2022 and achieve 90% coverage by 2025, as required by the Global Action Plan for Pneumonia and Diarrhea (GAPPD) and Immunisation Agenda 2030.

You May Also Like

Linked Country Case Study: Strengthening Tunisia’s HPV Vaccine Introduction

The Linked Immunisation Action Network played a pivotal role in supporting Tunisia’s HPV vaccine introduction by leveraging peer-to-peer learning and cross-regional collaboration. Tunisia joined the network in 2023 during critical preparations for its school-based HPV rollout targeting 12-year-old girls. Participation in global workshops, including an Istanbul session with peers like the Philippines and Mongolia, provided … Read More

Download
File size: 2.56M

Health and economic implications of adopting a 1-dose 9-valent human papillomavirus vaccination program in adolescents in LMICs: An analysis of Indonesia

A study in PLOS ONE evaluates the feasibility and impact of a single-dose 9-valent HPV vaccination program in Indonesia, focusing on its potential to reduce cervical cancer rates. The research highlights that a single-dose regimen is cost-effective, logistically simpler, and more accessible, particularly in low-resource settings. It also emphasizes the importance of community engagement and … Read More

HPV introduction and implementation: Case studies from Africa and South Asia

This special issue of Vaccine focuses on innovations and challenges in strengthening immunization programs globally. Key themes include the integration of new vaccine technologies, such as mRNA vaccines, into existing systems, and strategies to address inequities in vaccine access. Several articles highlight the importance of data-driven decision-making, supply chain resilience, and workforce training to improve … Read More